Unterehmen auf Watchlist setzen
Metagenomi
ISIN: US59102M1045
WKN: A4021A
Über
Unternehmensprofil
Tipp: Investor-Alerts aktivieren
Lassen Sie sich bei neuen Publikationen informieren
Tipp: AI-Factsheet

Corporate News meets AI! 
Analyse der Inhalte und Zusammenfassung

Metagenomi · ISIN: US59102M1045 · PR Newswire (ID: 20241029DC42671)
29 Oktober 2024 06:35PM

Lawsuit Deadline Notice: Metagenomi, Inc. Investors who lost over $100,000 with NASDAQ: MGX shares should contact the Shareholders Foundation


SAN DIEGO, Oct. 29, 2024 /PRNewswire/ -- The Shareholders Foundation, Inc. announces that a deadline is coming up on November 25th in the lawsuit that was filed for certain investors in Metagenomi, Inc. (NASDAQ: MGX) shares.

Investors who suffered losses in excess of $100,000 with shares of Metagenomi, Inc. (NASDAQ: MGX) have certain options and there are short and strict deadlines running. Deadline: November 25, 2024. Metagenomi, Inc. (NASDAQ: MGX investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

Metagenomi, Inc. completed its initial public offering on February 13, 2024. The Company sold about 6.25 million shares at $15 per share as part of the IPO. Less than three months later, on May 1, 2024, Metagenomi, Inc. announced that it and Moderna had "mutually agreed to terminate their collaboration" agreement. Since then shares of Metagenomi, Inc declined by more than 85%.

On September 26, 2024, a lawsuit was filed against Metagenomi, Inc. over alleged violations of Securities Laws. The plaintiff alleges that the Defendants made materially false and misleading statements regarding the Company's business, operations, and prospects. The action seeks to compensate investors who purchased shares in the company's initial public offering in February, 2024 and suffered losses as it seeks to recover damages they sustained because of Defendants' allegedly false and misleading statements.

Those who purchased Metagenomi, Inc. (NASDAQ: MGX) shares should contact the Shareholders Foundation, Inc.

CONTACT:

Shareholders Foundation, Inc.

Michael Daniels 

+1 (858) 779-1554 

mail@shareholdersfoundation.com 

3111 Camino Del Rio North 

Suite 423 

San Diego, CA 92108

The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. Any referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is only provided as a public service. It is not intended as legal advice and should not be relied upon.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/lawsuit-deadline-notice-metagenomi-inc-investors-who-lost-over-100-000-with-nasdaq-mgx-shares-should-contact-the-shareholders-foundation-302290072.html

SOURCE Shareholders Foundation, Inc.

Visuelle Wertentwicklung / Kursverlauf · Metagenomi
Smarte Analyse- und Recherchewerkzeuge finden Sie hier.
This publication was provided by our content partner PR Newswire
PR Newswire
via PR Newswire - Newsfeed
Cision ©2025
PR Newswire
Kontakt:
300 S Riverside Plaza, Chicago, Illinois, USA
+001 (0) 888-776-0942